These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 11145175)

  • 1. Effect of midodrine on chlorpromazine-induced orthostatic hypotension in rabbits: comparison with amezinium, etilefrine and droxidopa.
    Kurihara J; Takata Y; Suzuki S; Okubo Y; Kato H
    Biol Pharm Bull; 2000 Dec; 23(12):1445-9. PubMed ID: 11145175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of amezinium metilsulfate on the finger skin vasoconstrictor response to cold stimulation and venoconstrictor response to noradrenaline.
    Harada K; Ohmori M; Fujimura A; Ohashi K
    Jpn Circ J; 1998 Nov; 62(11):824-8. PubMed ID: 9856598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A rabbit model for evaluation of chlorpromazine-induced orthostatic hypotension.
    Takata Y; Kurihara J; Suzuki S; Okubo Y; Kato H
    Biol Pharm Bull; 1999 May; 22(5):457-62. PubMed ID: 10375164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dihydroergotamine and etilefrine on experimentally-induced postural hypotension in dogs.
    Yamazaki R; Tsuchida K; Otomo S
    J Pharmacobiodyn; 1990 Sep; 13(9):519-24. PubMed ID: 1707454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment on "Midodrine hydrochloride and L-threo-3,4-dihydroxy-phenylserine preserve cerebral blood flow in hemodialysis patients with orthostatic hypotension" by Fujisaki et al.
    Sharma V; Chan BP
    Ther Apher Dial; 2007 Oct; 11(5):407-8. PubMed ID: 17845403
    [No Abstract]   [Full Text] [Related]  

  • 6. Midodrine hydrochloride and L-threo-3,4-dihydroxy-phenylserine preserve cerebral blood flow in hemodialysis patients with orthostatic hypotension.
    Fujisaki K; Kanai H; Hirakata H; Nakamura S; Koga Y; Hattori F; Iida M
    Ther Apher Dial; 2007 Feb; 11(1):49-55. PubMed ID: 17309575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of droxidopa compared to midodrine in standing blood pressure and orthostatic tolerance in adults with neurogenic orthostatic hypotension: a systematic review protocol.
    Patrick K; Martin T
    JBI Database System Rev Implement Rep; 2017 Sep; 15(9):2287-2294. PubMed ID: 28902695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo pharmacodynamic interactions between two drugs used in orthostatic hypotension--midodrine and dihydroergotamine.
    Jourdan G; Verwaerde P; Pathak A; Tran MA; Montastruc JL; Senard JM
    Fundam Clin Pharmacol; 2007 Feb; 21(1):45-53. PubMed ID: 17227444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New developments in the management of neurogenic orthostatic hypotension.
    Biaggioni I
    Curr Cardiol Rep; 2014 Nov; 16(11):542. PubMed ID: 25303896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midodrine prescribed to improve recurrent post-spaceflight orthostatic hypotension.
    Platts SH; Ziegler MG; Waters WW; Mitchell BM; Meck JV
    Aviat Space Environ Med; 2004 Jun; 75(6):554-6. PubMed ID: 15198285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials.
    Chen JJ; Han Y; Tang J; Portillo I; Hauser RA; Dashtipour K
    Ann Pharmacother; 2018 Dec; 52(12):1182-1194. PubMed ID: 29972032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Treatment of Primary Orthostatic Hypotension.
    Hale GM; Valdes J; Brenner M
    Ann Pharmacother; 2017 May; 51(5):417-428. PubMed ID: 28092986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Midodrine. A review of its therapeutic use in the management of orthostatic hypotension.
    McClellan KJ; Wiseman LR; Wilde MI
    Drugs Aging; 1998 Jan; 12(1):76-86. PubMed ID: 9467688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders.
    McTavish D; Goa KL
    Drugs; 1989 Nov; 38(5):757-77. PubMed ID: 2480881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-hypotensive effects of M6434, an orally active alpha 1-adrenoceptor agonist, in rats.
    Dabasaki T; Shimojo M; Ishikawa H; Uemura A
    Jpn J Pharmacol; 1992 Jun; 59(2):145-50. PubMed ID: 1279249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midodrine for orthostatic hypotension.
    Med Lett Drugs Ther; 1997 Jun; 39(1003):59-60. PubMed ID: 9205432
    [No Abstract]   [Full Text] [Related]  

  • 17. Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension.
    Fouad-Tarazi FM; Okabe M; Goren H
    Am J Med; 1995 Dec; 99(6):604-10. PubMed ID: 7503082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease.
    Kremens D; Lew M; Claassen D; Goodman BP
    Clin Auton Res; 2017 Jul; 27(Suppl 1):29-31. PubMed ID: 28674867
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of neurogenic orthostatic hypotension with amezinium metilsulfate, a new indirect sympathomimetic drug.
    Kita K; Hirayama K
    Neurology; 1988 Jul; 38(7):1095-9. PubMed ID: 3386828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Droxidopa as an effective treatment for refractory neurogenic orthostatic hypotension and reflex bradycardia in amyloid light-chain amyloidosis: a case report.
    Ho AH; Kinter CW; Wight J; Neelam AR; Krakow D
    J Med Case Rep; 2020 Jun; 14(1):73. PubMed ID: 32560740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.